InvestorsHub Logo

dewophile

11/21/18 12:03 PM

#222431 RE: rogerm #222428

how does this compare to the SSRIs?
TIA

DewDiligence

03/19/19 5:55 PM

#224191 RE: rogerm #222428

FDA approves SAGE’s Zulresso (brexanolone) for postpartum depression:

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm633919.htm

Today was the (delayed) PDUFA date.